@article{a5983ee8d6a949588485c80c1b61931e,
title = "Lung Cancer Screening Eligibility and Referral Practices in Texas Organizations Serving People with Substance Use Disorders",
abstract = "For people at elevated risk for lung cancer, lung cancer screening (LCS) reduces lung cancer mortality. People with non-nicotine substance use disorders (SUDs) have elevated rates of smoking compared with the general population, highlighting them as a priority population for LCS consideration. Although research has shown LCS is underutilized, there is little literature to inform whether organizations that serve individuals with SUDs have existing clinical protocols surrounding LCS. In the current study, we examine the LCS eligibility and referral practices among these organizations. We conducted a statewide needs assessment survey in 2021 to discern how tobacco use was being addressed at Texas organizations that provide treatment or services to individuals with SUDs. Respondents were asked to report on their center{\textquoteright}s LCS eligibility and referral practices. The analytic sample consists of 125 respondents who represented 23 federally qualified health centers, 29 global local mental health authorities (LMHAs), 12 substance use treatment programs in LMHAs, and 61 standalone substance use treatment centers. Very few respondents indicated that healthcare providers at their center made referrals to LCS for patients (8.8%); a few respondents indicated that their healthcare providers assessed patients{\textquoteright} eligibility for LCS but did not make referrals (3.2%). Intervention and implementation efforts are needed in these and other SUD healthcare settings to bolster organizational capacity and ensure that patients are being navigated to lung cancer screening at multiple touch points across the care continuum.",
keywords = "cigarette smoking, early detection, lung cancer screening, substance use disorder treatment",
author = "Maggie Britton and Chen, {Tzuan A.} and {Martinez Leal}, Isabel and Anastasia Rogova and Bryce Kyburz and Teresa Williams and Mayuri Patel and Randa El-Zein and Bernicker, {Eric H.} and Lowenstein, {Lisa M.} and Reitzel, {Lorraine R.}",
note = "Funding Information: This project was supported by funding from the Department of State Health Services, contract HHS000961900001 to L.R.R. through the US Centers for Disease Control and Prevention, National and State Tobacco Control Program grant: NU58DP006805. Additionally, work on the manuscript and revision process was supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH), award R25DA054015 to L.R.R. as MPI, on which M.B. was a scholar and on which T.A.C. and A.R. were supported, and through a NOSI award (NOT-MD-22-001) funded by the NIDA of the NIH, through the National Institute on Minority Health and Health Disparities award U54MD015946-03S1 (PI: Dr. Ezemenari Obasi) to M.B. and I.M.L. as MPIs of the science and to L.R.R. as Co-I. Support on the revision process was additionally supported by the Cancer Prevention and Research Institute of Texas, award PP230002 to L.R.R. and M.B. as MPIs. Conclusions drawn in this work are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring organizations. Funding Information: The authors declare no conflict of interest; however, this work was funded by the Centers for Disease Control and Prevention through the Texas Department of State Health Services, who contracted with the research team. Co-author M.P. was a liaison between the research team and the Texas Department of State Health Services during the time of data collection and assisted us in promoting the opportunity to participate in the study (e.g., through her employer{\textquoteright}s newsletter, Community Resource Coordination Group meetings). She was, however, separated from the Texas Department of State Health Services at the time this data analysis was performed and the manuscript was written. The Centers for Disease Control and Prevention had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The Texas Department of State Health Services approved the recruitment plan and the use of the survey instruments that the research team created but had no direct role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
month = apr,
doi = "10.3390/cancers15072073",
language = "English (US)",
volume = "15",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",
}